{"data":{"issuanceinfo":{"industrycode":"204005","industry":"醫療保健","ipoprice":{"ceiling":"2.000","floor":"1.660"},"ipodate":{"start":"2017-12-07 00:00:00","end":"2017-12-12 00:00:00"},"minimumcapital":"4040.31","subscribed":"21.49","marketcap":"17.50億","H_marketcap":"--","pe":"20.21","codesrate":"60.00","link":"https://staticpdf.iqdii.com/stockdata/notice/Prospectus/01789/LTN20171207014_C.pdf","ipopricing":"1.750","resultdate":"2017-12-19 00:00:00","enddate":"2017-12-12 00:00:00","listeddate":"2017-12-20 00:00:00","issuenumber":"25000.00萬","issuenumberhK":"7500.00萬","issuenumberother":"17500.00萬","grayprice":"1.75","sponsors":"高盛(亞洲)有限責任公司","raisemoney":"36750.00萬","use":"1、約41.0%將主要用于我們常州設施的建設，并在較少程度上升級我們于北京現有的設施，及為常洲設施及我們于北京現有的設施收購新設備；\n2、約21.0%將用作開發及升級我們的3D打印產品及醫工交互平臺；\n3、約15.0%將用作其他研發活動；\n4、約15.0%將用于撥付能夠補充我們的現有產品組合、技術及業務增長的潛在收購及發展戰略聯盟；\n5、約8.0%將用作一般企業用途。","shares":2000,"leadagent":"高盛(亞洲)有限責任公司,國泰君安證券(香港)有限公司","bookrunners":"高盛(亞洲)有限責任公司","coordinator":"高盛(亞洲)有限責任公司","firstDayOpen":"1.75","IsEiio":0,"Interestdays":7,"PENote":"按經審核的最近年度公司股東應占溢利和發行后總股本計算；發行價未確定時，按招股價中間價計算；發行價確定后，按招股定價計算。","OverAllotment":"有","StabilizingManager":"高盛(亞洲)有限責任公司","code":"E01789","name":"愛康醫療","fullname":"愛康醫療控股有限公司"},"institutioninfo":{"principaloffice":"中國北京市昌平區科技園區白浮泉路10號","registrars":"卓佳證券登記有限公司","registrarstel":"(852) 2980 1333","chairman":"李志疆","secretary":"韓鈺,李昕穎","telephone":"(86010) 8010 9581","substantialshareholders":"李志疆及家族成員(56.40%),OrbiMed Advisors II Limited(7.23%),張朝陽(6.33%)","principalactivities":"公司是中國第一家且唯一一家將3D打印技術商業化且應用于骨關節及脊柱置換植入物的醫療器械公司，在中國骨關節植入物市場占據領先地位。設計、開發、生產及銷售骨科植入物，尤其專注于髖關節及膝關節置換植入物。","website":"http://www.ak-medical.net"},"managerinfo":[{"managername":"李志疆","post":"主席、行政總裁兼執行董事","rankno":1},{"managername":"張斌","post":"高級副總裁兼執行董事","rankno":2},{"managername":"張朝陽","post":"高級副總裁兼執行董事","rankno":3}],"investorinfo":[],"TotalShareholdingPercentage":0},"result":1,"Version":"4.5.190802.46408","ElapsedMilliseconds":523}